Provided by Tiger Fintech (Singapore) Pte. Ltd.

AKESO

121.500
+3.8003.23%
Volume:9.25M
Turnover:1.12B
Market Cap:111.90B
PE:-183.59
High:122.500
Open:119.100
Low:118.900
Close:117.700
52wk High:179.000
52wk Low:54.000
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:1.62
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.662
ROE:-14.61%
ROA:-4.41%
PB:15.88
PE(LYR):-183.59
PS:40.71

Loading ...

Company Profile

Company Name:
AKESO
Exchange:
SEHK
Establishment Date:
2012
Employees:
3529
Office Location:
No. 6, Shennong Road,Torch Development Zone,Zhongshan,Guangdong Province,China
Zip Code:
528437
Fax:
86 760 8987 3900
Introduction:
Akeso Inc is an investment holding company dedicated to the research, development, manufacturing and commercialization of antibody drugs that are affordable to patients worldwide. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The Company's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

Directors

Name
Position
XIA Yu
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
LI Bai Yong
Executive Director
WANG Zhong Min
Executive Director
ZHANG Peng
Executive Director
CENG Jun Wen
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
XU Yan
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
TAN Bo
Independent Director,Audit Committee Chairman
XIE Rong Gang
Director

Shareholders

Name
Position
XIA Yu
CEO,General Manager
LI Bai Yong
Vice General Manager,Chief Science Officer
WANG Zhong Min
Vice General Manager
XIA Yu
Vice General Manager
ZHANG Peng
Vice General Manager
Bing C. WANG
CFO
LIANG Hui Xin
Corporate Secretary